Department of Neuropsychiatry, Seoul National University Bundang Hospital, Seongnam, Republic of Korea.
Department of Ophthalmology, Seoul National University College of Medicine, Seoul, Republic of Korea.
JAMA Ophthalmol. 2021 May 1;139(5):548-556. doi: 10.1001/jamaophthalmol.2021.0320.
Retinal biomarkers reflecting in vivo brain Alzheimer disease (AD) pathologic abnormalities could be a useful tool for screening cognitively normal (CN) individuals at the preclinical stage of AD.
To investigate the association of both functional and structural alterations of the retina with in vivo AD pathologic abnormalities in CN older adults and model a screening tool for detection of preclinical AD.
DESIGN, SETTING, AND PARTICIPANTS: This cross-sectional study included a total of 49 CN individuals, and all assessment was done at the Seoul National University Hospital, Seoul, South Korea. All participants underwent complete ophthalmic examination, including swept-source optical coherence tomography (SS-OCT) and multifocal electroretinogram as well as amyloid-β (Aβ) positron emission tomography and magnetic resonance imaging. Data were collected from January 1, 2016, through October 31, 2017, and analyzed from February 1, 2018, through June 30, 2020.
For structural parameters of the retina, the thickness of the macula and layer-specific thicknesses, including peripapillary retinal nerve fiber layer and ganglion cell-inner plexiform layer measured by SS-OCT, were used for analysis. For functional parameters of the retina, implicit time and amplitude of rings 1 to 6 measured by multifocal electroretinogram were used.
Of the 49 participants, 25 were women (51.0%); mean (SD) age was 70.6 (9.4) years. Compared with 33 CN individuals without Aβ deposition (Aβ-CN), the 16 participants with Aβ (Aβ+CN) showed reduced inner nasal macular thickness (mean [SD], 308.9 [18.4] vs 286.1 [22.5] μm; P = .007) and retinal nerve fiber layer thickness, particularly in the inferior quadrant (133.8 [17.9] vs 103.8 [43.5] μm; P = .003). In addition, the Aβ+CN group showed prolonged implicit time compared with the Aβ-CN group, particularly in ring 5 (41.3 [4.0] vs 38.2 [1.3] milliseconds; P = .002). AD-related neurodegeneration was correlated with the thickness of the ganglion cell-inner plexiform layer only (r = 0.41, P = .005). The model to differentiate the Aβ+CN vs Aβ-CN groups derived from the results showed 90% accuracy.
The findings of this study showing both functional as well as structural changes of retina measured by multifocal electroretinogram and SS-OCT in preclinical AD suggest the potential use of retinal biomarkers as a tool for early detection of in vivo AD pathologic abnormalities in CN older adults.
反映体内大脑阿尔茨海默病(AD)病理异常的视网膜生物标志物可能是用于在 AD 的临床前阶段筛选认知正常(CN)个体的有用工具。
研究 CN 老年人的视网膜功能和结构改变与体内 AD 病理异常的关联,并建立用于检测临床前 AD 的筛查工具。
设计、地点和参与者:这是一项横断面研究,共纳入 49 名 CN 个体,所有评估均在韩国首尔国立大学医院进行。所有参与者均接受了全面的眼科检查,包括扫频源光学相干断层扫描(SS-OCT)和多焦视网膜电图以及淀粉样β(Aβ)正电子发射断层扫描和磁共振成像。数据于 2016 年 1 月 1 日至 2017 年 10 月 31 日采集,并于 2018 年 2 月 1 日至 2020 年 6 月 30 日进行分析。
对于视网膜的结构参数,使用 SS-OCT 测量的黄斑和特定层的厚度(包括视盘周围视网膜神经纤维层和神经节细胞-内丛状层)进行分析。对于视网膜的功能参数,使用多焦视网膜电图测量的环 1 至 6 的潜伏期和振幅。
49 名参与者中,有 25 名女性(51.0%);平均(SD)年龄为 70.6(9.4)岁。与 33 名无 Aβ 沉积的 CN 个体(Aβ-CN)相比,16 名有 Aβ 的参与者(Aβ+CN)的内鼻侧黄斑厚度降低(平均[SD],308.9[18.4]比 286.1[22.5]μm;P=0.007)和视网膜神经纤维层厚度,尤其是在下象限(133.8[17.9]比 103.8[43.5]μm;P=0.003)。此外,与 Aβ-CN 组相比,Aβ+CN 组的潜伏期延长,特别是在环 5(41.3[4.0]比 38.2[1.3]毫秒;P=0.002)。AD 相关的神经退行性变与神经节细胞-内丛状层的厚度仅相关(r=0.41,P=0.005)。从结果中得出的用于区分 Aβ+CN 与 Aβ-CN 组的模型显示出 90%的准确性。
本研究结果表明,在 AD 的临床前阶段,多焦视网膜电图和 SS-OCT 测量的视网膜功能和结构均发生改变,这提示视网膜生物标志物作为一种工具,可用于早期检测 CN 老年人的体内 AD 病理异常。